EUVIMEDEUVIMED entdecken
Scoping Review

Is imiquimod a promising drug to treat oral mucosa diseases? A scoping review and new perspectives

Victor de Mello Palma, Luiza Abrahão Frank, Daiana Moraes Balinha, Pantelis Varvaki Rados, Adriana Raffin Pohlmann, Silvia Stanisçuaski Guterres, Fernanda Visioli iD

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.15923 ↗

Kurz gefasst

Scoping Review in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Victor de Mello Palma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oral Medicine Department, School of Dentistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil, 90035-003. Hauptthemen laut MEDLINE: Mouth Mucosa, Drug Delivery Systems. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Imiquimod (IMQ) is a chemotherapeutic and immunostimulant drug that is applied topically, demonstrating antitumor and antiviral activities. The objective of this review was to compile data on the off‐label use of IMQ in oral mucosal diseases. IMQ has exhibited effectiveness in the treatment of various oral mucosal conditions, including oral carcinogenic lesions, neoplasms, HPV‐related lesions and autoimmune disorders. Although IMQ holds promise as a potential strategy for addressing oral mucosal lesions, it is important to note that significant side effects have been frequently reported. Nonetheless, it is crucial to develop and test new technological systems, such as the combination of nanotechnology with innovative drug delivery platforms. These advancements aim to minimize side effects and prolong the drug's contact time with the mucosa, preventing its removal by salivary flow.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth MucosaDrug Delivery SystemsHumansImiquimodPharmaceutical Preparations

Stichwörter der Autor:innen

imiquimodoff-label useoral diseasesoral mucosa

Substanzen

ImiquimodPharmaceutical Preparations

Autor:innen und Institutionen

  • Oral Medicine Department, School of Dentistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil, 90035-003.
  • Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Núcleo de Terapias Nanotecnológicas, Faculdade de Farmácia da Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Experimental Center Research, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil, 90035-903.

ORCID-Profile: Fernanda Visioli

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
  • São Paulo Research Foundation
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

de Mello Palma, V., Frank, L. A., Balinha, D. M., Rados, P. V., Pohlmann, A. R., Guterres, S. S., & Visioli, F. (2024). Is imiquimod a promising drug to treat oral mucosa diseases? A scoping review and new perspectives. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15923

Vancouver

de Mello Palma V, Frank LA, Balinha DM, Rados PV, Pohlmann AR, Guterres SS, et al. Is imiquimod a promising drug to treat oral mucosa diseases? A scoping review and new perspectives. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.15923

BibTeX
@article{deMelloPalma2024,
  author = {de Mello Palma, Victor and Frank, Luiza Abrahão and Balinha, Daiana Moraes and Rados, Pantelis Varvaki and Pohlmann, Adriana Raffin and Guterres, Silvia Stanisçuaski and Visioli, Fernanda},
  title = {Is imiquimod a promising drug to treat oral mucosa diseases? A scoping review and new perspectives},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.15923}
}
Kostenlos starten →